MACROMOLTEK INC
Macromoltek does computational drug discovery for pharma companies, focusing on antibodies for therapeutics and diagnostics. This mother-daughter teamโs approach aims to make research for everything from flu to cancer treatments an order of magnitude faster. With an accelerated process to discover antibodies, medical researchers can (1) craft targeted treatment plans for previously undruggable targets and (2) overcome patientsโ drug resistance, a major challenge when treating diseases caused by bacteria, viruses, and parasites.
MACROMOLTEK INC
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2010-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.macromoltek.com
Total Employee:
11+
Status:
Active
Total Funding:
1.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome
Current Employees Featured
Founder
Investors List
Y Combinator
Y Combinator investment in Seed Round - Macromoltek Inc
DCVC Bio
DCVC Bio investment in Seed Round - Macromoltek Inc
Neotribe Ventures
Neotribe Ventures investment in Seed Round - Macromoltek Inc
National Science Foundation
National Science Foundation investment in Grant - Macromoltek Inc
National Science Foundation
National Science Foundation investment in Grant - Macromoltek Inc
Newest Events participated
Official Site Inspections
http://www.macromoltek.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.65 K
- Host name: 199.60.103.88
- IP address: 199.60.103.88
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto

More informations about "Macromoltek Inc"
Macromoltek
Macromoltek is a computational drug discovery company dedicated to the advancement of antibody drug development through strategic partnerships.See details»
Macromoltek Inc - Crunchbase Company Profile & Funding
A process offered by Macromoltek to identify the specific parts of an antigen that antibodies bind to, aiding in vaccine and therapeutic development. Improving Antibody Structures: โฆSee details»
Macromoltek: Computational antibody design - Y โฆ
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs.See details»
Macromoltek - Team
Macromoltek started in 2010 and has spent the past 8 years creating antibody design and modeling software. Our team of engineers and scientists have a plethora of knowledge in โฆSee details»
Macromoltek Company Profile 2024: Valuation, โฆ
Developer of molecular modeling software designed to analyze potential antibody drug candidates. The company's platform uses its data algorithms to optimize the selection process, solves antibody structures computationally, and offers an โฆSee details»
Macromoltek Inc. - LinkedIn
We are revolutionizing antibody design. We design custom antibodies in one week using computational modeling. Our computational approach enables us to: - Discover antibodies for a single target -...See details»
Macromoltek, Inc. Company Profile | Austin, TX | Competitors ...
Find company research, competitor information, contact details & financial data for Macromoltek, Inc. of Austin, TX. Get the latest business insights from Dun & Bradstreet.See details»
Macromoltek - Contact
Macromoltek - Revolutionizing antibody design. Contact us! Macromoltek has a proven track record of producing reliable and innovative results.See details»
Macromoltek Inc - Funding, Financials, Valuation & Investors
Macromoltek does computational drug discovery for pharma companies, focusing on antibodies for therapeutics and diagnostics.See details»
Macromoltek Inc - Crunchbase
Macromoltek does computational drug discovery for pharma companies, focusing on antibodies for therapeutics and diagnostics.See details»
Monica Berrondo, PhD - Macromoltek | Antibody Engineering ...
Monica Berrondo, Ph.D., is an entrepreneur, scientist, and software engineer. Her expertise lies in antibody structure-prediction and analysis, protein functional analysis, protein mutational โฆSee details»
Monica Berrondo | World Building Institute
She is the founder and CEO of Macromoltek, a software company assisting biotech companies in improving research outcomes and reducing the cost associated with drug discovery through โฆSee details»
MACROMOLTEK, LLC - VentureRadar
Macromoltek is a computational drug discovery company dedicated to the advancement of antibody drug development through strategic partnerships. ... Find out more about โฆSee details»
Macromoltek Company Profile - Office Locations, Competitors
See insights on Macromoltek including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Macromoltek - Biotech Careers
Macromoltek is a computational drug discovery company dedicated to the advancement of antibody drug development through strategic partnerships. COVID-19: 04/2020, announced โฆSee details»
Macromoltek - Overview, News & Similar companies - ZoomInfo
Apr 7, 2020ย ยท View Macromoltek (www.macromoltek.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
Macromoltek Inc - Contacts, Employees, Board Members
Macromoltek Inc has 2 current employee profiles, including CTO & Co-Founder Susana Kaufmann. Macromoltek does computational drug discovery for pharma companies, focusing โฆSee details»
Macromoltek - Products, Competitors, Financials, Employees ...
Macromoltek is a computational drug discovery company that operates in the pharmaceutical industry. The company's main service is the design of custom antibodies using computational โฆSee details»
CYTOVIA Therapeutics and MACROMOLTEK to Develop Dual โฆ
Apr 7, 2020ย ยท Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. They have built a proprietary platform that enables โฆSee details»
Computational Design of Antibody Drugs for COVID-19
What is an antibody? Where do we target our designs? Which designs will actually work?See details»